Lost your libido? You may have your birth control to blame

Kent Holtorf, M.D.


A recent European study found that women who use birth control pills are more likely to experience sexual dysfunction such as reduced desire and arousal than women who use other non-hormonal contraception and women who do not use contraception.


UNT Health Science Center Researcher Offers Women Hormone Therapy Choice

PR Newswire-US Newswire

FORT WORTH, Texas, May 18, 2011 /PRNewswire-USNewswire/ -- In Texas, 340,000 people suffer with Alzheimer's disease, and that number is expected to grow to 470,000 by 2050.

The Pill and HRT Reduce Risk of Cerebral Aneurysms?


A controversial new study published in the Journal of NeuroInterventional Surgery suggests that those women who take birth control pills or undergo hormone replacement therapy are at a lower risk of developing cerebral aneurysms late in their lives.

Thyroid drug 'boosts risk of fractures in the elderly'


The BBC reports today, researchers writing in the British Medical Journal are concerned elderly people may be taking too much thyroxine which they say increases the risk of fractures.

Click here to read the full article

Renew Your Energy Right Now

Erika Schwartz, M.D.

In her new column in Newsmax Health, nationally renowned age management specialist Erika Schwartz, M.D. discusses how to renew and recharge your body’s energy system, bringing your hormones into balance, limiting the negative effects of inflammation, and boosting your immune system to fortify the body against the breakdown and weakness that allows disease to take hold.

Comment: All Hormones Are Not Created Equal

Erika Schwartz, M.D.

In an article this week in the New York Times’ Week In Review, Tara Parker-Hope does an excellent job documenting the doubt and confusion surrounding hormone replacement therapy (HRT) and the contentious results of the Women’s Health Initiative (WHI) study. Unfortunately, Ms. Parker-Hope commits the same error as scores of other journalists before her: oversimplification.

Comment: Health Outcomes of the WHI participants

David Brownstein, M.D.

A recent article in JAMA (4.6.11-Vol. 303, N.13, p. 1305) reported on the health outcomes of women after they stopped taking conjugated equine estrogens (CEE).  This study was a continuation of the Women’s Health Initiative (WHI) project.  This arm of the WHI studied the use of CEE (Premarin) in postmenopausal women with a prior hysterectomy.  The original WHI study was stopped after 7.1 years, due to an increase risk of stroke.  At this time, subjects were told to stop taking CEE. 

Male sex hormone testosterone 'interferes with empathy'


In an article published in PNAS this week, UK and Dutch researchers reported that the administration of a small dose of the male sex hormone testosterone to women makes them less able to empathise with others.

Click here to view related articles as reported by the media.

BHI Responds to WHI Follow-up Study

Bioidentical Hormone Initiative

As noted in The New York Times this week (Beast Cancer Seen as Riskier with Hormones), further research on the Women’s Health Initiative found that, as compared to placebo,  conventional HRT (i.e., Premarin and Provera) given after menopause was responsible for 25% more invasive breast cancers and 78% more likely to be breast cancer node-positive.  Compared to women given placebo, conventional HRT use was associated with a 96% increase in breast cancer-attributed death.   IF that were not enough,



BHI Online houses an archive of hormone-related citations for biomedical literature. Also provided are links to PubMed and the NCBI molecular biology resources.


BHI Online strives to support healthcare professionals through webinars presented by leading experts in their respective fields.


Join the conversation with BHI Online's forums aimed at providing information through communities.

Latest News

A selection of stories and articles making headlines in the field of Bioidentical Hormone therapies.

Get In Touch

Locate a BHRT doctor, submit an article or just say hello, we'd love to meet you.

Sub Page: Side Block 1

Sub Page: Side Block 2

Sub Page: Side Block 3

Sub Page: Side Block 4